相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study
Naim Ouldali et al.
LANCET INFECTIOUS DISEASES (2021)
Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era
Sara de Miguel et al.
CLINICAL INFECTIOUS DISEASES (2021)
Genome-wide proximity between RNA polymerase and DNA topoisomerase I supports transcription in Streptococcus pneumoniae
Maria-Jose Ferrandiz et al.
PLOS GENETICS (2021)
Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018
Zahin Amin-Chowdhury et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae
Myriam V. Valenzuela et al.
PLOS ONE (2020)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15
Brian Wahl et al.
LANCET GLOBAL HEALTH (2018)
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Christopher Troeger et al.
LANCET INFECTIOUS DISEASES (2018)
Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis
Maria T. Garcia et al.
FRONTIERS IN MICROBIOLOGY (2018)
Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016
Hisashi Shoji et al.
INFECTION AND DRUG RESISTANCE (2018)
An increase in negative supercoiling in bacteria reveals topology-reacting gene clusters and a homeostatic response mediated by the DNA topoisomerase I gene
Maria-Jose Ferrandiz et al.
NUCLEIC ACIDS RESEARCH (2016)
PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease
Elisa Ramos-Sevillano et al.
PLOS PATHOGENS (2016)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Secular trends (1990-2013) in serotypes and associated non-susceptibility of S-pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination
Asuncion Fenoll et al.
VACCINE (2015)
Pleiotropic Effects of Cell Wall Amidase LytA on Streptococcus pneumoniae Sensitivity to the Host Immune Response
Elisa Ramos-Sevillano et al.
INFECTION AND IMMUNITY (2015)
Fluoroquinolone-Resistant Pneumococci: Dynamics of Serotypes and Clones in Spain in 2012 Compared with Those from 2002 and 2006
Arnau Domenech et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Spread of Streptococcus pneumoniae Serotype 8-ST63 Multidrug-Resistant Recombinant Clone, Spain
Carmen Ardanuy et al.
EMERGING INFECTIOUS DISEASES (2014)
Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum
K. E. Bowker et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Applied Biological and Physicochemical Activity of Isoquinoline Alkaloids: Oxoisoaporphine and Boldine
Eduardo Sobarzo-Sanchez et al.
MOLECULES (2012)
Clonal Spread of Levofloxacin-Resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain, 2007 to 2009
Iciar Rodriguez-Avial et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV plus patients
J. C. Sanz et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
New Alkaloid Antibiotics That Target the DNA Topoisomerase I of Streptococcus pneumoniae
Maria Teresa Garcia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Population Structure of Invasive Streptococcus pneumoniae in the Netherlands in the Pre-Vaccination Era Assessed by MLVA and Capsular Sequence Typing
Karin E. M. Elberse et al.
PLOS ONE (2011)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Enhanced In Vivo Activity of Cefditoren in Pre-Immunized Mice against Penicillin-Resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a Sepsis Model
Fabio Cafini et al.
PLOS ONE (2010)
Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006
Heather J. Adam et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien et al.
LANCET (2009)
Changes in Fluoroquinolone-Resistant Streptococcus pneumoniae after 7-Valent Conjugate Vaccination, Spain
Adela G. de la Campa et al.
EMERGING INFECTIOUS DISEASES (2009)
High Protein Binding and Cidal Activity against Penicillin-Resistant S. pneumoniae: A Cefditoren In Vitro Pharmacodynamic Simulation
David Sevillano et al.
PLOS ONE (2008)
Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae
Jose Yuste et al.
PLOS PATHOGENS (2007)
Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae
S. Riedel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I
Bokun Cheng et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia
Luis Alou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones
Lorena Huelves et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae
D Tarragó et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance
JD Fuller et al.
CLINICAL INFECTIOUS DISEASES (2005)
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point
M Alkorta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Alkaloids from Cassytha filiformis and related aporphines:: Antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases
S Hoet et al.
PLANTA MEDICA (2004)
The Alexander Project 1998-2000:: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
MR Jacobs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Combined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model
J Yuste et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of β-lactams in a mouse sepsis model
J Casal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
β-Lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model
J Yuste et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
分享论文
